Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b
Clinical trial NCT03485846 · COMPLETED
Trial details
- NCT number
- NCT03485846
- Sponsor
- R-Pharm
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2018-08-29
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.